Luisa Matos do Canto
University of Southern Denmark
31 Papers
68 Citations
Luisa Matos do Canto is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 8, co-authored 25 publications. Previous affiliations of Luisa Matos do Canto include Georgetown University & Georgetown University Medical Center.
Chat about Author
Papers
Aging and menopause reprogram osteoclast precursors for aggressive bone resorption.
Anaïs Marie Julie Møller,Jean-Marie Delaissé,Jacob Bastholm Olesen,Jonna Skov Madsen,Luisa Matos do Canto,Troels Bechmann,Silvia Regina Rogatto,Kent Søe +7 more
TL;DR: It is concluded that monocytes are “reprogrammed” in vivo, allowing them to “remember” age, the menopausal status, and the bone formation status in vitro, resulting in more aggressive osteoclasts.
Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer
TL;DR: Evidence of their involvement in OC and the development of acquired resistance are compelling and warrant further investigation for clinical applications, and the prospects of using lncRNAs as biomarkers or targets for precision medicine in OC are discussed.
Metabolomic profiling of breast tumors using ductal fluid.
Luisa Matos do Canto,Catalin Marian,Rency S. Varghese,Jaeil Ahn,Patricia A. Da Cunha,Shawna C. Willey,Mary Sidawy,Janice D. Rone,Amrita K. Cheema,George Luta,Mohammad R. Nezami Ranjbar,Habtom W. Ressom,Bassem R. Haddad +12 more
TL;DR: This is the first study that shows the feasibility of conducting a comprehensive metabolomic profiling of breast tumors using breast ductal fluid to detect changes in the cellular microenvironment of the tumors and shows the potential for this approach to be used to improve detection of breast cancer.
Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study
Lars Henrik Jensen,Silvia Regina Rogatto,Jan Linderberg,Birgitte Mayland Havelund,Cecilie Abildgaard,Luisa Matos do Canto,Chris Aksel Vagn-Hansen,Claus Dam,Søren Rafael Rafaelsen,Torben Hansen +9 more
TL;DR: In this paper , the authors evaluated the feasibility and clinical outcome of using tumor-derived organoids to assess drug sensitivity at individual level and to suggest new treatment options or re-challenge.
Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer
Robson Francisco Carvalho,Luisa Matos do Canto,Cecilie Abildgaard,Mads M. Aagaard,Monica Søgaard Tronhjem,Marianne Waldstrøm,Lars Henrik Jensen,Karina Dahl Steffensen,Silvia Regina Rogatto +8 more
TL;DR: In this article , the authors comprehensively characterized the crosstalk between CAFs and ovarian cancer cells from malignant fluids to identify specific ligands and receptors mediating intercellular communications and disrupted pathways related to prognosis and therapy response.